| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61962189b5983d0e26959d56534afe00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a3191c9534ba25cdc3163c9731caa62a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68ce7e77aef8091b37df8c5c1abde3cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a5863225edb11773c698cebfa45f747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44e8b16f2fde63fecff0b10cc4f47e24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44faff7473f6d1572c2209ed46380327
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_892f2cdf07e0c7d44efa6c898721ac9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7f94d802bb1147020654d484f790de4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-04 |
| filingDate |
2006-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47c68f018e68458fc309aff8a5ceef1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_004d95d62b4a0d0b426cf351297b59bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ecd7a5ce812be5af86302a79041175a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dba6e0c90c6f8b32cad09f469515a716
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e60faef73f6bc5037cabfdc2dfc0d2fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa57580017134fae58df747db1f0e3d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ee336b5948da26a325ce0c63f8a1a91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f2e8a7da0ebaa99cdfe318de0a5aa4d |
| publicationDate |
2006-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006211630-A1 |
| titleOfInvention |
Novel synthetic compounds, processes of manufacture and uses in the treatment of integrin-mediated disorders |
| abstract |
This invention relates to nitroproline derivative compounds and procedures for their preparation and the preparation of pharmaceutical compositions containing the compounds. The invention also relates to the administration of compounds of the invention as agents for the treatment of mammalian diseases whose pathogenic and pathophysiological mechanisms depend on or are significantly contributed by undesirable cellular and molecular activities or responses induced by integrin-dependent molecular interactions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013057092-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013057096-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009126920-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9345766-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2860260-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8927694-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2510941-A2 |
| priorityDate |
2003-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |